Literature DB >> 12381477

Histological analysis of the products of conception following first trimester abortion at Jordan University Hospital.

Kamil M Fram1.   

Abstract

OBJECTIVE: To evaluate the value of histopathological examination of products of conception in first trimester abortion. SETTINGS: University hospital.
DESIGN: Retrospective record review over 2 years, from January 1999 to January 2001. PATIENTS: A total number of 293 patients with the diagnosis of first trimester abortion were admitted and their abnormal pregnancy evacuated.
RESULTS: The highest type of abortion among the studied group was incomplete abortion, 140 patients (48%), and surgical evacuation was the most common method of termination, 202 patients (69%). The histopathology reports confirmed the pregnancy in all patients and revealed partial mole in 51 patients (17%), undiagnosed abnormality in 8 patients (2.7%), suggesting the possible cause for recurrent pregnancy loss in 4 patients (1.4%).
CONCLUSION: Histopathological assessment for the products of conception proved to be an important tool in detecting molar pregnancy and hydropic changes that necessitate special follow-up protocol and unmasking ectopic pregnancies for further management.

Entities:  

Mesh:

Year:  2002        PMID: 12381477     DOI: 10.1016/s0301-2115(02)00155-0

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  Routine Histopathological Analysis of the Products of Conception: Is there a Value?

Authors:  Samuel Robsam Ohayi; Nnaemeka Thaddeus Onyishi
Journal:  Niger Med J       Date:  2020-07-04

2.  Value of histopathologic examination of uterine products after first-trimester miscarriage.

Authors:  Sharifa Ali Alsibiani
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

3.  The impact of pre-evacuation ultrasound examination in histologically confirmed hydatidiform mole in missed abortion.

Authors:  Yunhui Tang; Chenqi Zhu; Chen Zhu; Feng Liang; Arier Lee; Xiaoying Yao; Qi Chen
Journal:  BMC Womens Health       Date:  2020-09-10       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.